Key result
Renal transplantation normalizes LVEF in dilated cardiomyopathy linked to anti-troponin I antibodies.
Why the study?
Cardiomyopathy associated with dialysis has been shown to be reversible in some cases, but the immunological mechanisms involved remain unclear.
Case Report (n=1)
Renal transplant may reverse dialysis cardiomyopathy in select cases; leaves open anti-troponin antibody role pending larger studies.
Cardiomyopathy associated with dialysis has been shown to be reversible in some cases. A 58-year-old female patient with polycystic renal disease and end-stage renal disease had a renal transplant after 9 years on hemodialysis. Dilated cardiomyopathy with depressed left ventricular ejection fraction markedly improved after transplantation, with normalization of the ejection fraction. High titers for anti-troponin I antibodies were measured: IgG 1:640, IgM 1:80. In our case, the presence of anticardiac (anti-troponin I) antibodies may suggest that the syndrome of reversible cardiomyopathy seen after renal transplantation is associated with immunosuppression therapy acting on immunological mechanisms previously at play.
No takes yet. Share an insight, caveat, or question.
Nunes et al. (2013) conducted a case report in Dilated cardiomyopathy and end-stage renal disease (n=1). Renal transplant was evaluated on Left ventricular ejection fraction. Renal transplantation in a 58-year-old female with dilated cardiomyopathy resulted in normalization of left ventricular ejection fraction, associated with high anti-troponin I antibodies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: